UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006747
Receipt number R000007964
Scientific Title Evaluation of a chemiluminescent immunoassay for serum HE4
Date of disclosure of the study information 2011/12/09
Last modified on 2013/07/08 14:59:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of a chemiluminescent immunoassay for serum HE4

Acronym

Evaluation of serum HE4 assay

Scientific Title

Evaluation of a chemiluminescent immunoassay for serum HE4

Scientific Title:Acronym

Evaluation of serum HE4 assay

Region

Japan


Condition

Condition

Ovarian cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of HE4 assay - reference interval, cutoff, sensitivity and specificity

Basic objectives2

Others

Basic objectives -Others

Performance evaluation of a diagnostic test

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Sensitivity, Specificity

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Female

Key inclusion criteria

1. Ovarian tumor
- Female 20years oled or above, less than 80 years old.
- Ovarian mass suspected by ultrasound, MRI, or CT. Undergoing laparotomy/surgery.
- The first treatment is a laparotomy/surgery.
- Pathology results available within the study period.

2. Healthy subjects
- Female 20years oled or above, less than 80 years old.

Key exclusion criteria

1. Ovarian tumor
- The dirst treatment is chemotherapy and/or radiotherapy, not laparotomy/surgery.
- Pathology results on the primary tumor not available.

2. Healthy subjects
- History of bilateral oophorectomy.
- Abnormality found in ovary by MRI or PET.
- Aware of gynecological diseases.
- Aware of internal diseases.
- Aware of pregnancy.

Target sample size

470


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazunori Ochiai

Organization

The Jikei University School of Medicine

Division name

Obstetrics & Gynecology

Zip code


Address

3-25-8 Nishishinbashi, Minato-ku, Tokyo

TEL

03-3433-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

The Jikei University School of Medicine

Division name

Obstetrics & Gynecology

Zip code


Address

3-25-8 Nishishinbashi, Minato-ku, Tokyo

TEL


Homepage URL


Email



Sponsor or person

Institute

Abbott Japan Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

Abbott Japan Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学 附属病院(東京都)
東京慈恵会医科大学 附属柏病院(千葉県)
自治医科大学 附属病院(栃木県)
がん研有明病院(東京都)
立正佼成会附属佼成病院(東京都)
愛知県がんセンター中央病院(愛知県)
聖授会OCAT予防医療センター(大阪府)


Other administrative information

Date of disclosure of the study information

2011 Year 12 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 11 Month 07 Day

Date of IRB


Anticipated trial start date

2011 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Case-Control study


Management information

Registered date

2011 Year 11 Month 18 Day

Last modified on

2013 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007964